Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylation

被引:94
作者
Ertel, W
Keel, M
Infanger, M
Ungethüm, U
Steckholzer, U
Trentz, O
机构
[1] Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Div Plast Surg, CH-8091 Zurich, Switzerland
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 1998年 / 44卷 / 05期
关键词
D O I
10.1097/00005373-199805000-00005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The accumulation of neutrophils at inflammatory sites results in excessive release of toxic metabolites causing tissue injury. Proinflammatory cytokines may cause the breakdown of homeostasis of neutrophil numbers through inhibition of apoptosis. Methods: Neutrophils were isolated from healthy humans and from patients with multiple injuries on day of admission and during septic complications. Apoptosis was quantitated using propidium iodide fluorescence and the TUNEL method. Tyrosine phosphorylation was measured by flow cytometry. Results: Neutrophil apoptosis was decreased (33.3 +/- 5.5%; p < 0.05) in injured patients with sepsis compared with healthy humans (87.2 +/- 3.0%) and injured patients without sepsis (76.0 +/- 2.0%), Serum from injured patients with sepsis inhibited (p < 0.05) apoptosis of neutrophils from healthy humans in a dose-dependent manner. Serum from healthy humans and from injured patients at admission was ineffective. Neutralization of granulocyte-colony stimulating factor, but not of granulocyte-macrophage-colony stimulating factor, in serum of injured patients with sepsis partially abrogated (+51.2%) serum induced prolongation of neutrophil life span. Reduction of neutrophil apoptosis was concomitant with increased tyrosine phosphorylation. Conclusions: Septic complications, but not the injury itself, result in inhibition of spontaneous neutrophil apoptosis. Circulating mediators seem to reduce neutrophil apoptosis through up-regulation of tyrosine phosphorylation.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 50 条
  • [1] ADACHI S, 1993, EXP HEMATOL, V21, P1213
  • [2] ADACHI S, 1994, EUR J HAEMATOL, V53, P129
  • [3] ARMANT M, 1995, IMMUNOLOGY, V85, P331
  • [4] BERGAMASCHI G, 1993, LEUKEMIA, V7, P2012
  • [5] Biffl WL, 1996, ARCH SURG-CHICAGO, V131, P24
  • [6] SEPSIS SYNDROME - A VALID CLINICAL ENTITY
    BONE, RC
    FISHER, CJ
    CLEMMER, TP
    SLOTMAN, GJ
    METZ, CA
    BALK, RA
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (05) : 389 - 393
  • [7] BRACH MA, 1992, BLOOD, V80, P2920
  • [8] HIGH CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH SEPTIC SHOCK - EVOLUTION DURING SEPSIS, PROGNOSTIC VALUE, AND INTERPLAY WITH OTHER CYTOKINES
    CALANDRA, T
    GERAIN, J
    HEUMANN, D
    BAUMGARTNER, JD
    GLAUSER, MP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) : 23 - 29
  • [9] PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK
    CALANDRA, T
    BAUMGARTNER, JD
    GRAU, GE
    WU, MM
    LAMBERT, PH
    SCHELLEKENS, J
    VERHOEF, J
    GLAUSER, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) : 982 - 987
  • [10] THE KINETICS OF GRANULOPOIESIS IN NORMAL MAN
    CARTWRIGHT, GE
    ATHENS, JW
    WINTROBE, MM
    [J]. BLOOD, 1964, 24 (06) : 780 - 803